Thomas Cerny

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Daniel Betticher, Shu‐Fang Hsu Schmitz, Martin Tötsch et al. · Journal of Clinical Oncology · 2003 · 455 citations

Medicine, Oncology, Pharmacology +17

A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial

Jacques Cornuz, Susanne Zwahlen, W. F. Jungi et al. · PLoS ONE · 2008 · 284 citations · Full text

Veterinary Medicine, Immunology, Adaptive Immunity +11

Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98

Giovanni Martinelli, Shu‐Fang Hsu Schmitz, Urs Utiger et al. · Journal of Clinical Oncology · 2010 · 242 citations · Full text

Medicine, Immunology, Oncology +13

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Daniel Betticher, S-F Hsu Schmitz, Martin Tötsch et al. · British Journal of Cancer · 2006 · 208 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Michele Ghielmini, Shu‐Fang Hsu Schmitz, Sergio Cogliatti et al. · Journal of Clinical Oncology · 2004 · 197 citations · Full text

Medicine, Hematology, Pharmacotherapy +12